Arcadia Biosciences Income Statement (2014-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Jun2026
Revenue & cost
Revenue (Quarter)	837.00M	2.60M	4.30M	3.22M	3.86M	1.57M	-5.81M	1.23M	1.30M	1.30M	0.78M	0.99M	1.31M	1.54M	1.22M	1.20M	1.46M	1.30M	0.90M	1.44M
Cost of Revenue (Quarter)	1.59M	2.51M	3.75M	3.46M	3.45M	1.13M	0.90M	0.69M	0.65M	0.82M	0.18M	0.47M	0.63M	1.03M	0.83M	0.68M	0.82M	0.88M	0.71M	0.81M
Gross Profit (Quarter)	835.41M	0.09M	0.55M	-0.24M	0.41M	0.44M	-6.71M	0.54M	0.65M	0.48M	0.60M	0.52M	0.67M	0.51M	0.39M	0.52M	0.63M	0.42M	0.19M	0.63M
Operating items
Research & Development (Quarter)	1.13M	1.04M	0.56M	0.40M	0.36M	0.26M	0.50M	0.36M	0.03M	0.01M	0.01M	0.01M	0.01M	0.02M	0.01M		0.01M
Selling, General & Administrative (Quarter)	6.37M	6.31M	6.21M	4.35M	4.65M	4.18M	3.63M	4.07M	2.07M	1.86M	1.70M	2.06M	2.68M	2.24M	2.65M	1.74M	2.12M	1.57M	1.57M	1.13M
Other Operating Expenses (Quarter)	1.59M		-0.48M	0.33M	0.06M		-0.07M	0.02M					4.00M			0.75M
Restructuring Costs (Quarter)																	0.40M			0.35M
Operating Expenses (Quarter)																				2.78M
Operating Income (Quarter)																				-0.50M
EBIT (Quarter)																				-0.50M
Non-operating items
Non Operating Investment Income (Quarter)					1.14M
Interest & Investment Income (Quarter)									0.02M
Other Non Operating Income (Quarter)																				-2.78M
Net income details
EBT (Quarter)																				-0.50M
Tax Provisions (Quarter)		0.00M	0.00M			0.00M	0.01M		0.00M		0.01M				-1.48M
Profit After Tax (Quarter)																				-6.27M
Income from Non-Controlling Interests (Quarter)	-0.16M	-0.66M	-0.28M	-0.12M	-0.02M	-0.01M	-0.08M		-0.01M
Income from Continuing Operations (Quarter)																				-0.50M
Consolidated Net Income (Quarter)																				-0.50M
Income towards Parent Company (Quarter)																				-0.50M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)																				-0.50M
Additional items
EPS (Basic) (Quarter)																				-0.17
EPS (Diluted) (Quarter)																				-0.17
Shares Outstanding (Quarter)																				2.99M
Shares Outstanding (Diluted) (Quarter)																				2.99M
Shares Outstanding (Entity) (Quarter)																				2.41M
EBITDA (Quarter)																				-0.50M
Interest Expenses (Quarter)	0.07M	0.24M	-80.97M	0.00M	0.00M	0.00M								3.14M	28.37M	40.82M	261.55M	108.24M	30.48M
Tax Rate (Quarter)		-0.01%	0.00%			-0.04%	-0.41%		0.03%		-1.57%				36.63%

Research Tools

Datasets

Plans

Developers

Arcadia Biosciences RKDA Income Statement (2014-2026)

Research Tools

Datasets

Plans

Developers

Arcadia Biosciences RKDA Income Statement (2014-2026)

Create an account

Sign In

Reset Password